For people with inflammatory arthritis (e.g, Rheumatoid arthritis, Psoriatic Arthritis, Lupus), this risk is even higher because they experience more heart disease complications than the general population
GLP-1 agents examined in the analysis included semaglutide (Wegovy), dulaglutide (Trulicity), tirzepatide (Zepbound), exenatide (Byetta), liraglutide (Saxenda), and lixisenatide (Lyxumia)
[Google Scholar] 13
Wharton, S., Blevins, T., Connery, L., Rosenstock, J., Raha, S., Liu, R., Ma, X., Mather, K
The rise of weight-loss injections like Ozempic, Wegovy and Mounjaro has transformed millions of lives, but dentists are now warning of a new, unexpected side effect: 'Ozempic Mouth.' While 'Ozempic Face', the term coined for rapid facial fat loss linked to GLP-1 medications, has become widely known, experts are now seeing worrying changes to patients' oral health too
However, some medical conditions or implanted devices may affect eligibility, so proper evaluation is essential